Psoriasis Enrolling by Invitation Phase 4 Trials for Apremilast (DB05676)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Enrolling by Invitation4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03022617An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail PsoriasisTreatment